Nuvalent (NUVL) Enterprise Value (2020 - 2026)
Nuvalent (NUVL) posted Enterprise Value of -$1.3 billion for Q1 2026, up 6.16% on a QoQ basis from -$1.4 billion in Q4 2025, and down 19.96% year-over-year from -$1.6 billion in Q1 2025.
Nuvalent (NUVL) Enterprise Value (2020 - 2026) Analysis & Trends
Nuvalent's Enterprise Value history runs 7 years deep, the most recent figure standing at -$1.3 billion for Q1 2026.
- Quarterly Enterprise Value fell 19.96% year-over-year to -$1.3 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.3 billion (down 19.96% YoY) and the FY2025 annual result came in at -$1.4 billion, down 22.68% from the prior year.
- Enterprise Value was -$1.3 billion for Q1 2026 at Nuvalent, up from -$1.4 billion in the prior quarter.
- Across five years, Enterprise Value topped out at -$257.0 million in Q2 2022 and bottomed at -$1.4 billion in Q4 2025.
- A 5-year average of -$749.3 million and a median of -$691.8 million in 2024 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2024 — Enterprise Value slumped 182.71% — and 2025, when it grew 19.28%.
- Nuvalent's Enterprise Value stood at -$472.2 million in 2022, then plunged by 52.47% to -$719.9 million in 2023, then slumped by 55.34% to -$1.1 billion in 2024, then retreated by 22.68% to -$1.4 billion in 2025, then climbed by 6.16% to -$1.3 billion in 2026.
- Business Quant data shows NUVL's Enterprise Value at -$1.3 billion in Q1 2026, -$1.4 billion in Q4 2025, and -$943.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Nuvalent | 9.75 Bn | 9.75 Bn | - | -1.29 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.29 Bn |
| Dec 31, 2025 | -1.37 Bn |
| Sep 30, 2025 | -943.10 Mn |
| Jun 30, 2025 | -1.01 Bn |
| Mar 31, 2025 | -1.07 Bn |
| Dec 31, 2024 | -1.12 Bn |
| Sep 30, 2024 | -1.17 Bn |
| Jun 30, 2024 | -657.99 Mn |
| Mar 31, 2024 | -691.84 Mn |
| Dec 31, 2023 | -719.91 Mn |
| Sep 30, 2023 | -413.26 Mn |
| Jun 30, 2023 | -431.24 Mn |
| Mar 31, 2023 | -450.46 Mn |
| Dec 31, 2022 | -472.16 Mn |
| Sep 30, 2022 | -402.81 Mn |
| Jun 30, 2022 | -256.96 Mn |
| Mar 31, 2022 | -272.73 Mn |
| Dec 31, 2021 | -288.11 Mn |
| Sep 30, 2021 | -302.43 Mn |
| Dec 31, 2020 | -10.33 Mn |